Excessive megakaryocyte migration after thrombolytic therapy and benefit of aspirin with streptokinase
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 1992-08, Vol.340 (8817), p.492-493 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 493 |
|---|---|
| container_issue | 8817 |
| container_start_page | 492 |
| container_title | The Lancet (British edition) |
| container_volume | 340 |
| creator | Van Pampus, ElisabethC.M Huijgens, PeterC Verheugt, FreekW.A Langenhuijsen, MartM.A.C |
| description | |
| doi_str_mv | 10.1016/0140-6736(92)91819-T |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_webof</sourceid><recordid>TN_cdi_webofscience_primary_A1992JJ87700051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>014067369291819T</els_id><sourcerecordid>1354825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-d59e5c02a0bfcfad06e0dfcea87fa76904407b28667f84ade2ec7640ab9a4bbc3</originalsourceid><addsrcrecordid>eNqNkUFrFDEUgIModa3-A4U5eFBkapLJTJJLoSzVWgq9rOAtvMm8tLG7kyFJW_ffm-0s25t4Co_3fYF8IeQ9oyeMsu4rZYLWnWy6T5p_1kwxXa9ekAUTUtStkL9eksUBeU3epPSbUio62h6RI9a0QvF2Qdz5H4sp-QesNngDdxC3wW5zmfxNhOzDWIHLGKt8G8OmD-tt9rYMGGHaVjAOVY8jOp-r4CpIk49-rB59vq1SjjjlcOdHSPiWvHKwTvhufx6Tn9_OV8uL-ur6-4_l2VVtG65yPbQaW0s50N5ZBwPtkA7OIijpQHaaCkFlz1XXSacEDMjRyk5Q6DWIvrfNMRHzvTaGlCI6M0W_KY8yjJpdNbNLYnZJjObmqZpZFe3DrE33_QaHZ2nOVPYf93tIFtYuwmh9OmCioVyrpmBqxh6xDy5Zj6PFA3XGtOaXl0rK8g8tW_r81HcZ7sdc1C__rxb6dKaxtHzwGM3eGHxEm80Q_L8f_Bf_M64M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Excessive megakaryocyte migration after thrombolytic therapy and benefit of aspirin with streptokinase</title><source>Web of Science - Science Citation Index Expanded - 1992<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>MEDLINE</source><source>EBSCOhost Business Source Complete</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Van Pampus, ElisabethC.M ; Huijgens, PeterC ; Verheugt, FreekW.A ; Langenhuijsen, MartM.A.C</creator><creatorcontrib>Van Pampus, ElisabethC.M ; Huijgens, PeterC ; Verheugt, FreekW.A ; Langenhuijsen, MartM.A.C</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(92)91819-T</identifier><identifier>PMID: 1354825</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>LONDON: Elsevier Ltd</publisher><subject>Aspirin - adverse effects ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Cell Movement - drug effects ; Drug Therapy, Combination ; General & Internal Medicine ; Humans ; Life Sciences & Biomedicine ; Male ; Medical sciences ; Medicine, General & Internal ; Megakaryocytes - drug effects ; Middle Aged ; Myocardial Infarction - blood ; Myocardial Infarction - drug therapy ; Pharmacology. Drug treatments ; Science & Technology ; Streptokinase - adverse effects</subject><ispartof>The Lancet (British edition), 1992-08, Vol.340 (8817), p.492-493</ispartof><rights>1992</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>0</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wosA1992JJ87700051</woscitedreferencesoriginalsourcerecordid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0140-6736(92)91819-T$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,27201,27933,27934,46004</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4302983$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1354825$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Pampus, ElisabethC.M</creatorcontrib><creatorcontrib>Huijgens, PeterC</creatorcontrib><creatorcontrib>Verheugt, FreekW.A</creatorcontrib><creatorcontrib>Langenhuijsen, MartM.A.C</creatorcontrib><title>Excessive megakaryocyte migration after thrombolytic therapy and benefit of aspirin with streptokinase</title><title>The Lancet (British edition)</title><addtitle>LANCET</addtitle><addtitle>Lancet</addtitle><subject>Aspirin - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Cell Movement - drug effects</subject><subject>Drug Therapy, Combination</subject><subject>General & Internal Medicine</subject><subject>Humans</subject><subject>Life Sciences & Biomedicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine, General & Internal</subject><subject>Megakaryocytes - drug effects</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Science & Technology</subject><subject>Streptokinase - adverse effects</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EZCTM</sourceid><sourceid>EIF</sourceid><recordid>eNqNkUFrFDEUgIModa3-A4U5eFBkapLJTJJLoSzVWgq9rOAtvMm8tLG7kyFJW_ffm-0s25t4Co_3fYF8IeQ9oyeMsu4rZYLWnWy6T5p_1kwxXa9ekAUTUtStkL9eksUBeU3epPSbUio62h6RI9a0QvF2Qdz5H4sp-QesNngDdxC3wW5zmfxNhOzDWIHLGKt8G8OmD-tt9rYMGGHaVjAOVY8jOp-r4CpIk49-rB59vq1SjjjlcOdHSPiWvHKwTvhufx6Tn9_OV8uL-ur6-4_l2VVtG65yPbQaW0s50N5ZBwPtkA7OIijpQHaaCkFlz1XXSacEDMjRyk5Q6DWIvrfNMRHzvTaGlCI6M0W_KY8yjJpdNbNLYnZJjObmqZpZFe3DrE33_QaHZ2nOVPYf93tIFtYuwmh9OmCioVyrpmBqxh6xDy5Zj6PFA3XGtOaXl0rK8g8tW_r81HcZ7sdc1C__rxb6dKaxtHzwGM3eGHxEm80Q_L8f_Bf_M64M</recordid><startdate>19920822</startdate><enddate>19920822</enddate><creator>Van Pampus, ElisabethC.M</creator><creator>Huijgens, PeterC</creator><creator>Verheugt, FreekW.A</creator><creator>Langenhuijsen, MartM.A.C</creator><general>Elsevier Ltd</general><general>LANCET LTD</general><general>Lancet</general><scope>BLEPL</scope><scope>DTL</scope><scope>EZCTM</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19920822</creationdate><title>Excessive megakaryocyte migration after thrombolytic therapy and benefit of aspirin with streptokinase</title><author>Van Pampus, ElisabethC.M ; Huijgens, PeterC ; Verheugt, FreekW.A ; Langenhuijsen, MartM.A.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-d59e5c02a0bfcfad06e0dfcea87fa76904407b28667f84ade2ec7640ab9a4bbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Aspirin - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Cell Movement - drug effects</topic><topic>Drug Therapy, Combination</topic><topic>General & Internal Medicine</topic><topic>Humans</topic><topic>Life Sciences & Biomedicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine, General & Internal</topic><topic>Megakaryocytes - drug effects</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Science & Technology</topic><topic>Streptokinase - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Pampus, ElisabethC.M</creatorcontrib><creatorcontrib>Huijgens, PeterC</creatorcontrib><creatorcontrib>Verheugt, FreekW.A</creatorcontrib><creatorcontrib>Langenhuijsen, MartM.A.C</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 1992</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Pampus, ElisabethC.M</au><au>Huijgens, PeterC</au><au>Verheugt, FreekW.A</au><au>Langenhuijsen, MartM.A.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Excessive megakaryocyte migration after thrombolytic therapy and benefit of aspirin with streptokinase</atitle><jtitle>The Lancet (British edition)</jtitle><stitle>LANCET</stitle><addtitle>Lancet</addtitle><date>1992-08-22</date><risdate>1992</risdate><volume>340</volume><issue>8817</issue><spage>492</spage><epage>493</epage><pages>492-493</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><cop>LONDON</cop><pub>Elsevier Ltd</pub><pmid>1354825</pmid><doi>10.1016/0140-6736(92)91819-T</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 1992-08, Vol.340 (8817), p.492-493 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_webofscience_primary_A1992JJ87700051 |
| source | Web of Science - Science Citation Index Expanded - 1992<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; MEDLINE; EBSCOhost Business Source Complete; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Aspirin - adverse effects Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Cell Movement - drug effects Drug Therapy, Combination General & Internal Medicine Humans Life Sciences & Biomedicine Male Medical sciences Medicine, General & Internal Megakaryocytes - drug effects Middle Aged Myocardial Infarction - blood Myocardial Infarction - drug therapy Pharmacology. Drug treatments Science & Technology Streptokinase - adverse effects |
| title | Excessive megakaryocyte migration after thrombolytic therapy and benefit of aspirin with streptokinase |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T09%3A39%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Excessive%20megakaryocyte%20migration%20after%20thrombolytic%20therapy%20and%20benefit%20of%20aspirin%20with%20streptokinase&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Van%20Pampus,%20ElisabethC.M&rft.date=1992-08-22&rft.volume=340&rft.issue=8817&rft.spage=492&rft.epage=493&rft.pages=492-493&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(92)91819-T&rft_dat=%3Cpubmed_webof%3E1354825%3C/pubmed_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/1354825&rft_els_id=014067369291819T&rfr_iscdi=true |